CANRENOIC ACID: 140 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
140
Total FAERS Reports
9 (6.4%)
Deaths Reported
77
Hospitalizations
140
As Primary/Secondary Suspect
3
Life-Threatening
First Report: 200210 · Latest Report: 20241031
What Are the Most Common CANRENOIC ACID Side Effects?
#1 Most Reported
Toxic epidermal necrolysis
33 reports (23.6%)
#2 Most Reported
Hyperkalaemia
33 reports (23.6%)
#3 Most Reported
Off label use
24 reports (17.1%)
All CANRENOIC ACID Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Hyperkalaemia | 33 | 23.6% | 0 | 29 |
| Toxic epidermal necrolysis | 33 | 23.6% | 8 | 0 |
| Drug hypersensitivity | 24 | 17.1% | 0 | 0 |
| Off label use | 24 | 17.1% | 0 | 0 |
| Product use in unapproved indication | 20 | 14.3% | 0 | 0 |
| Asthenia | 16 | 11.4% | 0 | 9 |
| Hyponatraemia | 14 | 10.0% | 0 | 13 |
| Epistaxis | 13 | 9.3% | 0 | 13 |
| Dehydration | 11 | 7.9% | 0 | 10 |
| Acute kidney injury | 10 | 7.1% | 0 | 8 |
| Hypotension | 10 | 7.1% | 0 | 8 |
| International normalised ratio increased | 10 | 7.1% | 0 | 10 |
| Bradycardia | 9 | 6.4% | 0 | 9 |
| Syncope | 9 | 6.4% | 0 | 7 |
| Dyspnoea | 8 | 5.7% | 0 | 4 |
| Metabolic acidosis | 8 | 5.7% | 0 | 5 |
| Oliguria | 8 | 5.7% | 2 | 6 |
| Blister | 7 | 5.0% | 7 | 0 |
| Headache | 7 | 5.0% | 0 | 6 |
| Loss of consciousness | 7 | 5.0% | 0 | 5 |
Who Reports CANRENOIC ACID Side Effects? Age & Gender Data
Gender: 49.6% female, 50.4% male. Average age: 70.0 years. Most reports from: IT. View detailed demographics →
Is CANRENOIC ACID Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2002 | 8 | 8 | 0 |
| 2006 | 24 | 0 | 0 |
| 2011 | 6 | 0 | 6 |
| 2014 | 1 | 0 | 1 |
| 2017 | 12 | 0 | 9 |
| 2018 | 11 | 0 | 7 |
| 2019 | 44 | 0 | 35 |
| 2020 | 8 | 0 | 5 |
| 2021 | 7 | 1 | 5 |
| 2022 | 6 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 4 | 0 | 4 |
What Is CANRENOIC ACID Used For?
| Indication | Reports |
|---|---|
| Hypertension | 57 |
| Product used for unknown indication | 25 |
| Ill-defined disorder | 21 |
| Cardiac failure | 8 |
| Renal impairment | 7 |
| Acute coronary syndrome | 5 |
CANRENOIC ACID vs Alternatives: Which Is Safer?
CANRENOIC ACID vs CANRENONE
CANRENOIC ACID vs CANTHARIDIN
CANRENOIC ACID vs CAPECITABINE
CANRENOIC ACID vs CAPIVASERTIB
CANRENOIC ACID vs CAPLACIZUMAB
CANRENOIC ACID vs CAPLACIZUMAB-YHDP
CANRENOIC ACID vs CAPMATINIB
CANRENOIC ACID vs CAPREOMYCIN
CANRENOIC ACID vs CAPSAICIN
CANRENOIC ACID vs CAPTOPRIL
Official FDA Label for CANRENOIC ACID
Official prescribing information from the FDA-approved drug label.